SMOOTH-MUSCLE AND BONE NEOPLASMS IN TRANSGENIC MICE EXPRESSING SV40 T-ANTIGEN

被引:0
|
作者
WILKIE, TM
SCHMIDT, RA
BAETSCHER, M
MESSING, A
机构
[1] UNIV WASHINGTON,HOSP PATHOL RC72,SEATTLE,WA 98195
[2] BIOTRANSPLANT INC,BOSTON,MA 02129
[3] UNIV WISCONSIN,SCH VET MED,MADISON,WI 53706
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transgenic mice carrying the SV40 early region fused to the Drosophila hsp70 promoter developed smooth muscle and bone neoplasms. The smooth muscle tumors appeared in aged mice and were preferentially located on the muzzle or eyelids. Multiple neoplasms were often present and each appeared to be an independent proliferation. In contrast, the bone tumors typically developed in the petrous ridge and had all the features of osteogenic sarcomas, displaying distant metastasis and invasion of the brain. Cells in both types of tumors exhibited nuclear expression of SV40 T antigen. Mice homozygous for the transgene had a shorter latency for appearance of smooth muscle tumors and developed osteosarcomas more frequently than hemizygous mice. This model system implicates the cellular T antigen-binding proteins, such as Rb and p53, in the pathogenesis of bone and soft tissue neoplasms in mice.
引用
收藏
页码:2889 / 2895
页数:7
相关论文
共 50 条
  • [1] SV40 T-ANTIGEN ACTS AS A MINOR HISTOCOMPATIBILITY ANTIGEN OF SV40 T-ANTIGEN TOLERANT TRANSGENIC MICE
    JURETIC, A
    KNOWLES, BB
    IMMUNOGENETICS, 1989, 29 (06) : 366 - 370
  • [2] SV40 T-ANTIGEN IS A HISTOCOMPATIBILITY ANTIGEN OF SV40-TRANSGENIC MICE
    WETTSTEIN, PJ
    JEWETT, L
    FAAS, S
    BRINSTER, RL
    KNOWLES, BB
    IMMUNOGENETICS, 1988, 27 (06) : 436 - 441
  • [3] CHRONIC THROMBOCYTOPENIA IN TRANSGENIC MICE EXPRESSING MEGAKARYOCYTE TARGETED SV40 T-ANTIGEN
    ROBINSON, MO
    ZHOU, W
    HOKOM, M
    DANELINKO, D
    HUNT, P
    BOSSELMAN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 235 - 235
  • [4] HYPOMYELINATING PERIPHERAL NEUROPATHIES AND SCHWANNOMAS IN TRANSGENIC MICE EXPRESSING SV40 T-ANTIGEN
    MESSING, A
    BEHRINGER, RR
    WRABETZ, L
    HAMMANG, JP
    LEMKE, G
    PALMITER, RD
    BRINSTER, RL
    JOURNAL OF NEUROSCIENCE, 1994, 14 (06): : 3533 - 3539
  • [5] SV40 TRANSGENIC MICE THAT DEVELOP TUMORS ARE IMMUNOLOGICALLY TOLERANT TO SV40 T-ANTIGEN
    FAAS, SJ
    PAN, S
    PINKERT, CA
    BRINSTER, RL
    KNOWLES, BB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 56 - 56
  • [6] Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen
    Marcus, DM
    Lasudry, JGH
    Carpenter, JL
    Windle, J
    Howes, KA
    AlUbaidi, MR
    Baehr, W
    Overbeek, PA
    Font, RL
    Albert, DM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (02) : 392 - 396
  • [7] SV40 T-ANTIGEN DISRUPTS MEGAKARYOCYTE DIFFERENTIATION IN TRANSGENIC MICE
    ROBINSON, MO
    ZHOU, W
    HOKOM, M
    DANELINKO, D
    HUNT, P
    BOSSELMAN, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1028 - 1028
  • [8] THYMIC EPITHELIAL NEOPLASMS IN TRANSGENIC MICE EXPRESSING SV40 T-ANTIGEN UNDER THE CONTROL OF AN ERYTHROID-SPECIFIC ENHANCER
    TEITZ, T
    CHANG, JC
    KAN, YW
    YEN, TSB
    JOURNAL OF PATHOLOGY, 1995, 177 (03): : 309 - 315
  • [9] PURKINJE-CELL DEATH IN TRANSGENIC MICE EXPRESSING AN INTACT OR TRUNCATED FORM OF SV40 T-ANTIGEN
    CLARK, HB
    ORR, HT
    EHLENFELDT, R
    YUNIS, WS
    FEDDERSEN, RM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 286 - 286
  • [10] Development of thymic carcinoma in transgenic mice expressing SV40 T antigen
    Park, WY
    Kim, JI
    Shim, EH
    Lee, WH
    Kim, SH
    Seo, JW
    Jang, JJ
    Seo, JS
    CANCER LETTERS, 1996, 107 (02) : 293 - 300